Black women with breast cancer were found to be three times more likely than their white counterparts to delay treatment for more than 90 days—a time delay associated with increased deaths from the disease, according to ...
May 7, 2013
0
0
For women diagnosed with a form of breast cancer known as estrogen receptor positive (ER+) breast cancer, tamoxifen is an essential drug used in the treatment and prevention of recurring breast cancer. Currently, tamoxifen ...
Apr 18, 2013
0
1
One-quarter of women who should take hormone-blocking therapies as part of their breast cancer treatment either do not start or do not complete the five-year course, according to a new study led by University of Michigan ...
Apr 9, 2013
0
1
(Medical Xpress)—Younger women who wait at least 15 years after their first menstrual period to give birth to their first child may reduce their risk of an aggressive form of breast cancer by up to 60 percent, according ...
Dec 12, 2012
0
0
Regular mammography screening can help narrow the breast cancer gap between black and white women, according to a retrospective study published in Breast Cancer Research and Treatment in August.
Sep 25, 2012
0
0
(Medical Xpress) -- Cell cultures are homogeneous. Human tumors are not. A University of Colorado Cancer Center study recently published in the journal Breast Cancer Research and Treatment reports the development of human-derived ...
Aug 6, 2012
0
0
As the nation struggles with soaring health care costs, a new report by RTI International shows that younger women diagnosed with breast cancer face a significant treatment burden.
May 3, 2017
0
1
The quality of a woman's social networks—the personal relationships that surround an individual—appears to be just as important as the size of her networks in predicting breast cancer survival, Kaiser Permanente scientists ...
Nov 9, 2012
0
0
A new Indiana University study is the first of its kind to show it may be possible to improve memory and thought process speed among breast cancer survivors.
Oct 3, 2012
0
0
Using biological markers—genetic characteristics that are associated with some patients with breast cancer—can increase the success rate of clinical trials for breast cancer drugs by almost 50 per cent, says new research ...
Oct 1, 2012
0
0
